Clinical trial
Study of Escitalopram in the Treatment of Specific Phobia
NCT00121069 · Connor, Kathryn M., M.D., Other · Completed
Key facts
| NCT number | NCT00121069 |
|---|---|
| Title | Study of Escitalopram in the Treatment of Specific Phobia |
| Official title | Placebo-Controlled Pilot Study of Escitalopram in the Treatment of Specific Phobia |
| Lead sponsor | Connor, Kathryn M., M.D., Other |
| Collaborators | Forest Laboratories Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Phobic Disorders |
| Intervention type | Drug |
| Interventions | Escitalopram |
| Enrollment | 12 |
| Start date | Sep 1, 2002 |
| Completion | Sep 1, 2004 |
| First posted | Jul 21, 2005 |
| Last update posted | Jul 21, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: